Paulus W, Grothe C, Sensenbrenner M, Janet T, Baur I, Graf M, Roggendorf W
Institut für Hirnforschung, Universität Tübingen, Federal Republic of Germany.
Acta Neuropathol. 1990;79(4):418-23. doi: 10.1007/BF00308718.
Fibroblast growth factor (FGF) is a potent angiogenic factor and a mitogen for a variety of mesoderm- and neuroectoderm-derived cell types (e.g., fibroblasts, endothelial cells, astrocytes, oligodendrocytes). After application of a monospecific polyclonal antiserum, we localized basic FGF on frozen sections of 73 human brain tumors using immunohistochemistry. FGF was present in a variable number of tumor cells (16/16 astrocytomas, 5/5 ependymomas, 0/3 benign and 4/7 anaplastic oligodendrogliomas, 11/12 glioblastomas, 11/11 meningiomas, 6/6 neurilemmomas, 0/3 pituitary adenomas, 2/2 choroid plexus papillomas, 0/1 neurocytoma, 2/2 benign fibrous histiocytomas, 2/5 metastatic carcinomas). FGF was detected in vascular cells of 59 tumors and in fibroblasts of connective tissue stroma from all papillomas and metastases. These results tend to indicate FGF involvement in the malignant progression of gliomas due to an autocrine or paracrine action. Histopathological aspects of malignant gliomas (e.g., pseudopalisading or pathological vessels) could be related to FGF activity.
成纤维细胞生长因子(FGF)是一种强大的血管生成因子,也是多种中胚层和神经外胚层来源的细胞类型(如成纤维细胞、内皮细胞、星形胶质细胞、少突胶质细胞)的促有丝分裂原。应用单特异性多克隆抗血清后,我们采用免疫组织化学方法在73例人脑肿瘤的冰冻切片上定位碱性FGF。FGF存在于数量不等的肿瘤细胞中(16/16例星形细胞瘤、5/5例室管膜瘤、0/3例良性和4/7例间变性少突胶质细胞瘤、11/12例胶质母细胞瘤、11/11例脑膜瘤、6/6例神经鞘瘤、0/3例垂体腺瘤、2/2例脉络丛乳头状瘤、0/1例神经细胞瘤、2/2例良性纤维组织细胞瘤、2/5例转移癌)。在59例肿瘤的血管细胞以及所有乳头状瘤和转移瘤的结缔组织基质中的成纤维细胞中检测到FGF。这些结果倾向于表明FGF通过自分泌或旁分泌作用参与胶质瘤的恶性进展。恶性胶质瘤的组织病理学特征(如假栅栏状或病理性血管)可能与FGF活性有关。